| Tag | Content |
|---|
EnhancerAtlas ID | HS110-02605 |
Organism | Homo sapiens |
Tissue/cell | KATO3 |
Coordinate | chr2:25028580-25029520 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr2:25029468-25029483 | ATTGCTGAGTCATAG | - | 7.88 | | Nfe2l2 | MA0150.2 | chr2:25029470-25029485 | TGCTGAGTCATAGGA | - | 6.17 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_40476 | chr2:25028943-25029774 | K562 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH02I024805 | chr2 | 25028801 | 25028950 | | GH02I024806 | chr2 | 25029494 | 25029926 |
|
Enhancer Sequence | GTGTGAGGTG TCAGTCTGCC TCTACTGGGG GATGCCTCCC AGTTAGGCTA CTCGGGGGTC 60
AGGGACCCAC TTGAGGAGGC AGTCTGTCTG TTCTCAGACC TCCAGCTGCG TGCTGGGAGA 120
ACCACTACTC TCTTCAAACT ATCAGACAGG GACATTTAAG TCTGCAGAGT TTTCTGCTGC 180
CTTTTGTTTT GCTATGCCCT GCCCCCAGAG GTGGAGTCTA CAGAGGCAGG CAGGCCTCCT 240
TGAGCTGCAG TGGGCTCCAC CCAGTTCGAG CTTCCAGGCT GCTTTGTTTA CCTATCCAAG 300
CCTCGGCAAG GGCGGGCGCC CCTCCCCCAG CCTTGCTGCT GCCTTGCAGT TTGATCTCAG 360
CCTGTTGTGC TAGCAATGAG CAGGCTCTGT GGGCGTAGGA CCCTCTGAGC CAGGCGCGGG 420
ATATAATCTC CTGGTGTGCC GTTTGCTAAG ACCGTTGGAA AAGCGCAGTA TTGGGGTGGG 480
AGTGACCCGA TTTTCCAGGT GCCGTCTGTC ACCCCTTTCT TTGACTAGGA AAGGGAACTC 540
CCTGACCCCT TGCGCTTCCT GGGTGAGGCG ATGCCTCGCC CTGCTTTGGC TCACACTCGG 600
TGTGCTGCAA CCACTGTCCT GCACCCACGG TCCGACACTT CCCAGAGAGA TGAACCTGGT 660
ACCTCAGTTG GAAATGCGGA AATCACCCGT CTTCTGCGTT GCTCACGCTG GGAGCTGTAG 720
ACTGGGGCTG TTCCTATTCG GCCATCTTGG CTCCACCCCC TCACCTAACA TTTGTCAGGC 780
ACTACTGGTA AGCCAGGCAA GTTCTTCCTG ACAGGTTCTT AACCTGCCCT AATAAACACC 840
TAAGTTTGTT ACCTCAATCA TATACATATT GGGTATATGC CTGGTAGAAT TGCTGAGTCA 900
TAGGATATGC ATATTCGGTT TAGTAAATAC TGCCAGTTTT 940
|
